Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
I-Mab Announces Upcoming Participation at May Conferences
2021-04-29 20:00
Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing
2021-04-29 19:47
2021, a turning point for PQE Group: no more internal hierarchy and a hiring plan of 550 new employees
2021-04-29 18:18
Hilco Industrial Acquires All Machinery & Equipment from Legacy Pharmaceutical Switzerland
2021-04-29 13:04
Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment
2021-04-29 08:34
Alphamab announced PD-L1/CTLA-4 bispecific antibody KN046 will enter new Phase II clinical trial in combination with Pfizer's Inlyta® (axitinib)
2021-04-29 08:00
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
2021-04-29 08:00
Essence Group Announces 'Peace of Mind' Strategy as Top Objective of All Future IoT Products and Services
2021-04-29 07:01
CAS launches new brand reflecting strategic evolution to empower smarter science
2021-04-29 04:53
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test"
2021-04-28 21:00
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2
2021-04-28 20:00
CROs dMed and Clinipace Merge to Accelerate Customer Success
2021-04-28 20:00
I-Mab Filed 2020 Annual Report on Form 20-F
2021-04-28 20:00
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology
2021-04-28 19:59
Turn Biotechnologies completes latest round of funding
2021-04-28 19:50
GenScript Launches Research-Grade Lentiviral Vector Packaging Service
2021-04-28 19:30
Samsung Biologics Reports First Quarter 2021 Financial Results
2021-04-28 16:37
Mentice publishes the company's interim report for the period January-March 2021
2021-04-28 15:53
Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute
2021-04-28 15:00
New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services
2021-04-28 14:00
1
529
530
531
532
533
1508